Imatinib (QTI571) in Pulmonary Arterial Hypertension

Update Il y a 4 ans
Reference: NCT00902174

Woman and Man

Extract

A multinational, multicenter, double blind, placebo-controlled study evaluating the efficacy and safety of imatinib as an add-on therapy in the treatment of patients with severe pulmonary arterial hypertension (PAH).


Inclusion criteria

  • pulmonary arterial hypertension


Links